US2012179027A1PendingUtilityA1

Fiduciary markers and method of use thereof

Assignee: SUTHANTHIRAN KRISHNANPriority: Jun 13, 2006Filed: Mar 21, 2012Published: Jul 12, 2012
Est. expiryJun 13, 2026(expired)· nominal 20-yr term from priority
A61B 90/39A61B 5/064A61N 5/1049
35
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides devices and methods used to locate target areas within a patient for repeat therapeutic treatments. In the invention, fiduciary markers made of metal or metal alloys are placed within a patient near or at a target site as reference coordinates for particular body locations on the patient. Repeat treatments may then be given to the patient over a period of time based on the coordinates given by the fiduciary markers. The fiduciary markers are specially shaped or put into strand to improve marker attachment and prevent marker migration.

Claims

exact text as granted — not AI-modified
1 . A marker for locating regions of interest in a subject comprising of at least one radio-opaque seed,
 a. wherein said radio-opaque seed remains readily detectable in vivo using common imaging modalities; and   b. said marker being sized and shaped for firm implantation into tissue or organ of said subject;   c. said radio-opaque seed has a length ranging from 0.1 mm to 5 cm;   d. said radio-opaque seed is made of a biocompatible metal or alloy of metals;   e. said radio-opaque seed have a proximal end and a distal end; and   f. a plurality of fingers is affixed to said distal end of the radio-opaque seed.   
     
     
         2 . A marker of  claim 1 , wherein said radio-opaque seed is made of a metal or metal alloy comprising as least one metal or metal alloy selected from the group consisting of stainless steel, gold, titanium, platinum, tantalum, copper, and tungsten. 
     
     
         3 . A marker of  claim 1 , wherein said radio-opaque seed is made of titanium. 
     
     
         4 . A marker of  claim 1 , wherein said radio-opaque seed can be of any shape. 
     
     
         5 . A marker of  claim 1 , wherein
 a. said distal end of the radio-opaque seed is shaped as a cone;   b. said proximal end of the radio-opaque seed is shaped as a ball; and   c. said proximal end and distal end is connected by a substantial cylindrical portion.   
     
     
         6 . A marker of  claim 5 , wherein the fingers
 a. remain closed before said seed is implanted into the subject; and   b. open up when said seed is implanted into a desired tissue within the subject.   
     
     
         7 . A marker of  claim 1 , wherein at least one said radio-opaque seed is enclosed in absorbable material forming substantially a strand. 
     
     
         8 . A marker of  claim 7 , wherein in the absorbable material is made of a polymer selected from a group consisting of
 a. a Polydextran;   b. a Polyvinylpyrrolidone;   c. a Poly(bis(p-carboxyphenoxy)-propane); or   d. a Biopolymer.   
     
     
         9 . A marker of  claim 7 , wherein at least two said radio-opaque seed is separated by at least one absorbable spacer. 
     
     
         10 . A marker of  claim 9 , wherein said absorbable spacer is made of a polymer selected from a group consisting of
 a. a Polydextran;   b. a Polyvinylpyrrolidone;   c. a Poly(bis(p-carboxyphenoxy)-propane); or   d. a Biopolymer.   
     
     
         11 . A marker of  claim 10 , wherein said biopolymer is selected from group consisting of gelatin, human serum albumin, and cellulose. 
     
     
         12 . A marker of  claim 1 , wherein at least one said radio-opaque seed is wrapped in surgical suture. 
     
     
         13 . A marker of  claim 12 , wherein at least two said radio-opaque seeds are wrapped in surgical suture to form a strand. 
     
     
         14 . A marker of  claim 13 , wherein at least two said radio-opaque seed is separated by at least one absorbable spacer. 
     
     
         15 . A marker of  claim 14 , wherein said absorbable spacer is made of a polymer selected from a group consisting of
 a. a Polydextran;   b. a Polyvinylpyrrolidone;   c. a Poly(bis(p-carboxyphenoxy)-propane); or   d. a Biopolymer.   
     
     
         16 . A marker of  claim 19 , wherein said biopolymer is selected from group consisting of gelatin, human serum albumin, and cellulose. 
     
     
         17 . A method of locating a region of interest in a subject for treatment using a marker, comprising the following steps:
 a. producing a marker comprising of at least one radio-opaque seed wherein said seed remains readily detectable in vivo using common imaging modalities; and sized and shaped for firm implantation into tissue or organ of said subject;   b. implanting one or more of said marker into said tissue or organ close to or at said region of interest   c. opening a plurality of fingers on said radio-opaque seed;   d. fixing said radio-opaque seed into tissue;   e. detecting said marker in vivo using common imaging modalities;   f. locating said region of interest using said markers as reference points; and   g. delivering treatment to the region of interest.   
     
     
         18 . A method of  claim 17 , wherein said common imaging modalities includes:
 a. Stereotaxy;   b. Ultrasound;   c. CT; or   d. MRI.   
     
     
         19 . A method of  claim 18 , wherein said markers are implanted using one of the following method:
 a. an implantation gun;   b. a catheter; and   c. a syringe.   
     
     
         20 . A method of  claim 19 , wherein said marker
 a. is implanted for a period of time,   b. is used in a series of treatments; and   c. is removed after said treatments.

Join the waitlist — get patent alerts

Track US2012179027A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.